临床病理学预测结果和附加疗法在病理学II期非小细胞肺癌中的影响
Yi-Wen Shen1, Tai-Huang Lee2, Hui-Yang Hung2
1Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
Anticancer research
|January 30, 2026
概括
瘤大小,结节状况和腺癌亚型在第二阶段非小细胞肺癌 (NSCLC) 中显著影响复发. 识别高风险患者对于优化辅助疗法和确保基于价值的护理至关重要.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 癌症研究 癌症研究
背景情况:
- 病理性II期非小细胞肺癌 (NSCLC) 在治愈切除后显示出可变的结果.
- 像EGFR-TKI和免疫疗法这样的辅助疗法在II期NSCLC中提供了有限的益处.
- 确定预后因素对于个性化治疗和成本有效的护理至关重要.
研究的目的:
- 在切除的II期NSCLC中确定复发和生存的独立预后因素.
- 引导治疗决策,以优化辅助疗法选择.
- 在NSCLC管理中支持基于价值的精密护理策略.
主要方法:
- 对115名患有病态II期非小细胞癌 (IIA和IIB) 的患者进行了回顾性分析,这些患者接受了完全切除.
- 评估临床病理学变量,包括瘤大小,结节状况和组织学亚型.
- 使用Kaplan-Meier和Cox比例危险模型评估无复发生存率 (RFS) 和整体生存率 (OS).
主要成果:
- 五年RFS和OS率分别为50.9%和67.9%.
- 复发的独立预测因素包括瘤大小>4厘米,N1结节状况和高风险腺癌亚型 (micropapillary/solid).
- 辅助化疗显著改善了OS (76.4%与37.2%,p=0.002).
结论:
- 瘤大小,结节参与和组织学亚型是第二阶段NSCLC的关键预后决定因素.
- 识别高风险患者对于优化辅助免疫疗法或向治疗选择至关重要.
- 这些预后因素有助于确保辅助治疗的临床疗效和经济效益.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Outcomes of Glycolysis
107.2K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.2K
Predicting Reaction Outcomes
10.8K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K


